Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXA2R | P21731 | 9/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | PTGFR | P43088 | 3/20 | 0.52 |
| ▸ | SLCO2A1 | Q92959 | 3/20 | 0.52 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.52 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.52 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.52 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | HTR2B | P41595 | 1/20 | 0.48 |
| ▸ | MC3R | P41968 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.48 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10071927 | 1.00 | TBXA2R (0.52) | TBXA2RALDH1A1LMNAPTGFRSLCO2A1 | |
| SCHEMBL13587661 | 1.00 | TBXA2R (0.52) | TBXA2RALDH1A1LMNAPTGFRSLCO2A1 | |
| SCHEMBL10072387 | 0.96 | TBXA2R (0.53) | TBXA2RALDH1A1LMNAPTGFRSLCO2A1 | |
| SCHEMBL1696531 | 0.96 | TBXA2R (0.53) | TBXA2RALDH1A1LMNAPTGFRSLCO2A1 | |
| SCHEMBL5114583 | 0.96 | TBXA2R (0.53) | TBXA2RALDH1A1LMNAPTGFRSLCO2A1 | |
| SCHEMBL11837676 | 0.95 | TBXA2R (0.54) | TBXA2RALDH1A1LMNAPTGFRSLCO2A1 | |
| SCHEMBL7615146 | 0.93 | LMNA (0.50) | TBXA2RALDH1A1LMNAPTGFRSLCO2A1 | |
| SCHEMBL1696521 | 0.87 | PDE4D (0.67) | TBXA2RALDH1A1LMNAPTGFRSLCO2A1 | |
| SCHEMBL13587652 | 0.87 | PDE4D (0.67) | TBXA2RALDH1A1LMNAPTGFRSLCO2A1 | |
| SCHEMBL13587904 | 0.87 | TBXA2R (0.46) | TBXA2RALDH1A1LMNAPTGFRSLCO2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140212441-A1 | PHARMACEUTICAL COMPOSITION FOR INFLAMMATORY DISEASES, ALLERGIC DISEASES AND AUTOIMMUNE DISEASES | R-TECH UENO, LTD. (JP) | 2014-07-31 | — | — | US | disclosed |
| US-20140171496-A1 | COMPOSITION AND METHOD FOR PROMOTING HAIR GROWTH | R-TECH UENO, LTD. (JP) | 2014-06-19 | — | — | US | disclosed |
| US-20140171496-A1 | COMPOSITION AND METHOD FOR PROMOTING HAIR GROWTH | R-TECH UENO, LTD. (JP) | 2014-06-19 | — | — | US | disclosed |
| US-20120088823-A1 | COMPOSITION AND METHOD FOR SCALP AND HAIR TREATMENT | R-TECH UENO, LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088823-A1 | COMPOSITION AND METHOD FOR SCALP AND HAIR TREATMENT | PTGER3, PTGDR2, HSD3B2 | TBXA2R 2683/4885ALDH1A1 2791/4885LMNA 3494/4885 |
| US-20140171496-A1 | COMPOSITION AND METHOD FOR PROMOTING HAIR GROWTH | COX15, PGF, PTGS2 | TBXA2R 2772/4885ALDH1A1 1951/4885LMNA 2174/4885 |
| US-20140212441-A1 | PHARMACEUTICAL COMPOSITION FOR INFLAMMATORY DISEASES, ALLERGIC DISEASES AND AUTOIMMUNE DISEASES | IL5, ALOX5, TSLP | TBXA2R 151/4885ALDH1A1 624/4885LMNA 4478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.